Recent News

• 03.18.2025 - Prime Medicine Unveils Program for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
• 03.18.2025 - Prime Medicine Unveils Program for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
• 03.03.2025 - TD Cowen 45th Annual Health Care Conference
• 03.03.2025 - TD Cowen 45th Annual Health Care Conference
• 02.28.2025 - Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates
• 02.28.2025 - Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates
• 02.24.2025 - Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference
• 02.24.2025 - Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference

Recent Filings

• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.28.2025 - 8-K Current report
• 02.28.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.28.2025 - EX-99.1 EX-99.1